➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Medtronic
AstraZeneca
Colorcon
Moodys

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019955


Email this page to a colleague

« Back to Dashboard

NDA 019955 describes DDAVP, which is a drug marketed by Ferring Pharms Inc and is included in three NDAs. It is available from three suppliers. Additional details are available on the DDAVP profile page.

The generic ingredient in DDAVP is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
Summary for 019955
Tradename:DDAVP
Applicant:Ferring Pharms Inc
Ingredient:desmopressin acetate
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 019955
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DDAVP desmopressin acetate TABLET;ORAL 019955 NDA Ferring Pharmaceuticals Inc. 55566-2600 55566-2600-0 1 BOTTLE in 1 CARTON (55566-2600-0) > 100 TABLET in 1 BOTTLE
DDAVP desmopressin acetate TABLET;ORAL 019955 NDA Ferring Pharmaceuticals Inc. 55566-2700 55566-2700-0 1 BOTTLE in 1 CARTON (55566-2700-0) > 100 TABLET in 1 BOTTLE
Paragraph IV (Patent) Challenges for 019955
Tradename Dosage Ingredient NDA Submissiondate
DDAVP TABLET;ORAL desmopressin acetate 019955

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.1MG
Approval Date:Sep 6, 1995TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.2MG
Approval Date:Sep 6, 1995TE:ABRLD:Yes

Expired US Patents for NDA 019955

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
AstraZeneca
Boehringer Ingelheim
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.